Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
27,96 USD | +0,25 % | -0,94 % | -0,48 % |
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biopharmaceutical Royalties
100,0
%
| 2 237 | 100,0 % | 2 355 | 100,0 % | +5,24 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 237 | 100,0 % | 2 355 | 100,0 % | +5,24 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Pablo Legorreta
CEO | Chief Executive Officer | 60 | 01/01/96 |
Terrance Coyne
DFI | Director of Finance/CFO | 42 | 01/01/10 |
Eric Schneider
CTO | Chief Tech/Sci/R&D Officer | - | 21/09/23 |
James Reddoch
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/07/08 |
Arthur McGivern
CIO | Chief Investment Officer | - | 12/10/22 |
Sara Klymkowsky
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/12 |
Brienne Kugler
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/14 |
George Lloyd
CIO | Chief Investment Officer | 64 | 01/01/11 |
Christopher Hite
BRD | Director/Board Member | 57 | 01/03/20 |
George Grofik
IRC | Investor Relations Contact | - | 01/01/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Rory Riggs
FOU | Founder | 71 | 01/01/96 |
Errol de Souza
BRD | Director/Board Member | 70 | 01/06/20 |
David Hodgson
BRD | Director/Board Member | 67 | 23/06/22 |
Ted Love
BRD | Director/Board Member | 65 | 30/07/20 |
Henry Fernandez
BRD | Director/Board Member | 65 | 30/07/20 |
Gregory Norden
BRD | Director/Board Member | 66 | 11/02/20 |
Pablo Legorreta
CEO | Chief Executive Officer | 60 | 01/01/96 |
Mario Giuliani
BRD | Director/Board Member | 52 | 01/06/20 |
Bonnie Bassler
BRD | Director/Board Member | 61 | 16/06/20 |
Christopher Hite
BRD | Director/Board Member | 57 | 01/03/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 50 000 | 0 | 0 | 95,08 % |
Acción B | 1 | 150 743 276 | 0 | 0 | |
Acción C | 1 | 446 691 515 | 424 704 211 ( 95,08 %) | 0 |
Información de la empresa
Royalty Pharma Plc
110 East 59th Street 33rd floor
10022, New York
+212 883 0200
http://www.royaltypharma.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Royalty Pharma Holdings Ltd.
Royalty Pharma Holdings Ltd. Financial ConglomeratesFinance Royalty Pharma Holdings Ltd. operates as an investment holding company. The company was founded on February 10, 2020 and is headquartered in Bristol, the United Kingdom. |
Financial Conglomerates
|
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-0,69 % | 12,46 mil M | |
+25,88 % | 672 mil M | |
+24,08 % | 550 mil M | |
-6,63 % | 351 mil M | |
+14,63 % | 317 mil M | |
+6,57 % | 292 mil M | |
+3,17 % | 211 mil M | |
+0,60 % | 203 mil M | |
-10,96 % | 144 mil M | |
-8,00 % | 141 mil M |
- Bolsa de valores
- Acciones
- Acción RPRX
- Empresa Royalty Pharma plc